Get started
Author

Kou Kimoto

Observed name: Kimoto, Kou
ORCID: 0009-0006-3834-8901
Observed ORCID: 0009-0006-3834-8901
OpenAlex ID: A5042393150
SARS‐CoV‐2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID‐19
2021 · Hitoshi Kawasuji, Yoshitomo Morinaga, et al. · Journal of Medical Virology · 58
PDF
Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis
2023 · Hitoshi Kawasuji, Kentaro Nagaoka, et al. · Antibiotics · 56
PDF
Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients
2021 · Hitoshi Kawasuji, Yasuhiro Tsuji, et al. · BMC Pharmacology and Toxicology · 45
PDF
Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5
2023 · Hitoshi Kawasuji, Yoshitomo Morinaga, et al. · Microbiology Spectrum · 16
Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19
2021 · Hitoshi Kawasuji, Yoshitomo Morinaga, et al. · Scientific Reports · 14
PDF
A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test
2021 · Yushi Murai, Hitoshi Kawasuji, et al. · International Journal of Infectious Diseases · 14
PDF
Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients
2021 · Hitoshi Kawasuji, Yasuhiro Tsuji, et al. · Antibiotics · 12
PDF
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection
2024 · Hitoshi Kawasuji, Yoshitomo Morinaga, et al. · Frontiers in Immunology · 8
PDF
High feasibility of salivary therapeutic drug monitoring in linezolid, but lower feasibility in tedizolid: a single-dose study in healthy subjects and a monocentric prospective exploratory study in patients who received linezolid
2025 · Hitoshi Kawasuji, Yasuhiro Tsuji, et al. · Journal of Antimicrobial Chemotherapy · 5
PDF
Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants
2023 · Kentaro Nagaoka, Hitoshi Kawasuji, et al. · Viruses · 4
PDF
Association between high serum favipiravir concentrations and drug-induced liver injury
2021 · Hitoshi Kawasuji, Yasuhiro Tsuji, et al. · medRxiv · 4
PDF
Association between sore throat and early immune responses against COVID-19 before and after the emergence of the Omicron variant
2024 · Yusuke Takegoshi, Kentaro Nagaoka, et al. · Annals of Translational Medicine · 3
High Incidence of Metastatic Infections in Panton-Valentine Leucocidin-Negative, Community-Acquired Methicillin-Resistant Staphylococcus aureus Bacteremia: An 11-Year Retrospective Study in Japan
2023 · Hitoshi Kawasuji, Yoshihiro Ikezawa, et al. · Antibiotics · 2
PDF
Acute bronchopneumonia with Bordetella bronchiseptica bacteremia in an immunocompromised patient with bronchiectasis: A case report and review of the literature
2026 · Yoshinori Takahashi, Ryosuke Isshiki, et al. · Journal of Infection and Chemotherapy · 1
Successful 30-Day Nirmatrelvir/Ritonavir Treatment of a Patient Who Developed Multi-relapsed COVID-19 After Receiving R-CHOP Against Follicular Lymphoma
2025 · Kou Kimoto, Hitoshi Kawasuji, et al. · Cureus · 1
PDF
Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4–5 vaccine and practical application of dried blood spots
2024 · Hitoshi Kawasuji, Yoshitomo Morinaga, et al. · Vaccine · 1
Investigation of nasopharyngeal viral load at discharge in patients with COVID-19
2021 · Yasutaka Fukui, Hitoshi Kawasuji, et al. · Journal of Infection and Chemotherapy · 1
PDF
Microbiota-based Antimicrobial resistance Risk Screening (MARS): a novel PCR method for dynamic assessment of AMR colonization risk and ESBL carrier identification
2025 · Hitoshi Kawasuji, Yoshitomo Morinaga, et al. · Research Square
PDF
Comparative Study of Three Commercial Blood (1→3)-β-D-glucan Detection Reagents for Invasive Mycosis
2023 · Yuki Miyajima, Kentaro Nagaoka, et al. · Medical Mycology Journal
PDF
Works count: 23
Citation count: 245
H-index: 8
I10-index: 7
Year
Topic
Type